Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with 'Neurophet AQUA'

Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with 'Neurophet AQUA'

New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysis Accelerating global expansion with cutting-edge technology targeting MS, a prevalent condition in North America and...

menu
menu